SMO ClinPlus Co. Ltd. (301257) — Capital Reinvestment Ratio
SMO ClinPlus Co. Ltd. (301257) has a Capital Reinvestment Ratio of 0.22x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥35.69 Million) in capital expenditures (CN¥7.83 Million). Check 301257 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SMO ClinPlus Co. Ltd. Capital Reinvestment Ratio (2019–2025)
This chart tracks SMO ClinPlus Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see 301257 cash flow conversion.
Annual Capital Reinvestment Ratio for SMO ClinPlus Co. Ltd. (2019–2025)
Year-by-year Capital Reinvestment Ratio for SMO ClinPlus Co. Ltd. from 2019 to 2025. See cash generation quality of SMO ClinPlus Co. Ltd. to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥35.69 Million | CN¥7.83 Million | ▲ +146.0% |
| 2023 | 0.09x | CN¥114.85 Million | CN¥10.25 Million | ▼ -54.6% |
| 2022 | 0.20x | CN¥40.44 Million | CN¥7.95 Million | ▲ +85.4% |
| 2021 | 0.11x | CN¥41.52 Million | CN¥4.40 Million | ▼ -41.7% |
| 2020 | 0.18x | CN¥22.45 Million | CN¥4.08 Million | ▲ +68.6% |
| 2019 | 0.11x | CN¥45.53 Million | CN¥4.91 Million | — |